Somatropin HGH 50IU | Pack size: 10 IU, Primary purpose: Muscle growth and recovery, Secondary purpose: Fat reduction and improved definition

New Free

Somatropin HGH 50IU

Somatropin stimulates protein synthesis, lipolysis and recovery processes. It supports lean muscle mass and reduction of subcutaneous fat when combined with nutrition and a training program. It is often used during recomposition periods or when better recovery is needed. It is combined with sleep/stress hygiene, a protein-rich diet and structured strength/cardio sessions.

0 reviews • Write a review

€ 90.00 (176.03лв)

Ex Tax: € 90.00 (176.03лв)

Qty

Add to Cart

Buy Now Question?

Add to Wish List

Ask a Question about this Product

Shipping

Secure and safe worldwide delivery! If the product is on stock - average delivery time is 2-3 days in Eastern Europe, 3-7 days in Western Europe and 1-3 weeks world wide!

Improved storage formula

Improved storage formula - increased stability and extended shelf life!

Quality Control & Tests

High-quality product! All peptides branded MyPeptid are produced in 100% laboratory conditions and have purity above 98%. Our products are tested at JINOSHIK, Analiza Białek and other independent, established laboratories with high standards!

Tags: Muscle growth and recovery

Product information
Reviews

This peptide helps the body use food more efficiently for building and maintaining tissues, directs energy toward recovery, and influences how reserves are distributed and stored.

Somatropin HGH 50IU

Agonist activation of the human growth hormone receptor (GHR) triggers JAK2/STAT signaling and downstream cascades (incl. MAPK and PI3K/AKT), which is the molecular basis of the effects of recombinant somatropin as a biologically active analogue of endogenous GH; its synthesis and regulation are described in Wikipedia (Somatropin), as well as in regulatory and clinical sources such as FDA (Drug Approvals & labeling) and EMA.

Mechanism of action (MoA)

Binding to GHR induces dimerization/conformational change and phosphorylation of JAK2, leading to transcriptional programs that increase expression of IGF‑1 (liver and peripheral tissues) and metabolic effects on lipolysis, protein turnover and glucose homeostasis. For laboratory purposes this enables modeling of the GH–IGF axis and quantitative monitoring of markers such as IGF‑1, pSTAT5, as well as metabolic readouts.

Clinical/preclinical data

study name	population or experimental model	number of subjects or samples	duration	key observed outcomes
No numerical results included here	—	—	—	Public regulatory and review sources confirm clinical use of somatropin, but within the scope of this brief B2B description specific numerical endpoints are not cited without unambiguously referenced tables/figures from primary publications. It is recommended to extract numerical data directly from the SmPC/label (FDA/EMA) or peer-reviewed articles.

Context of scientific use | laboratory and clinical settings

In laboratory settings Somatropin is used for in vitro stimulation of GHR-positive cell lines, ex vivo tissue systems and in vivo models of GH‑deficiency/metabolic phenotypes, with dose control in IU and monitoring of IGF‑1/STAT5 phosphorylation. In the clinical setting (outside the scope of this product) somatropin is a licensed drug; for scientific interpretation of the safety profile and indications use FDA/EMA.

Purity and specification

Somatropin HGH 10IU by MyPeptid provides conditions for analytical validation and reproducible bioassays, as it has a purity above 99% (per declared specification) and is suitable for QC approaches such as HPLC/LC‑MS and bioactivity via pSTAT5/reporter assays. Research‑only means that batches are intended for methods, analyses and tests, and not for therapeutic use.